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addition, the study supports a selective physiological effect ofParacellin-1 is critical for magnesium and calcium reabsorption
basolateral Mg21 and Ca21 concentration on TAL divalentin the human thick ascending limb of Henle.
cation paracellular permeability, that is, PCLN-1 activity.Background. A new protein, named paracellin 1 (PCLN-1),
expressed in human thick ascending limb (TAL) tight junctions,
possibly plays a critical role in the control of magnesium and
calcium reabsorption, since mutations of PCLN-1 are present
Magnesium balance is regulated by kidneys that adaptin the hypomagnesemia hypercalciuria syndrome (HHS). How-
magnesium excretion to net magnesium intestinal ab-ever, no functional experiments have demonstrated that TAL
magnesium and calcium reabsorption were actually impaired sorption. In experimental models, the thick ascending
in patients with HHS. limb of Henle (TAL), and especially the cortical TAL,
Methods. Genetic studies were performed in the kindred of is the main site of magnesium transport, accounting for
two unrelated patients with HHS. Renal magnesium and cal-
60 to 70% of overall magnesium reabsorption [1]. In thiscium reabsorption in TAL were analyzed in one homozygous
tubular segment, magnesium transport is mainly (if notaffected patient of each family, one patient with extrarenal
hypomagnesemia (ERH), and two control subjects (CSs). exclusively) passive via the paracellular pathway, and is
Results. We found two yet undescribed mutations of PCLN-1 driven by the prevailing lumen-positive transepithelial
(Gly 162 Val, Ala 139 Val). In patients with HHS, renal magne- potential difference generated by transcellular NaCl re-
sium and calcium reabsorptions were impaired as expected;
absorption [2]. Thus, two conditions are required forNaCl renal conservation during NaCl deprivation and NaCl
the paracellular magnesium reabsorption in the corticaltubular reabsorption in diluting segment were intact. Furose-
mide infusion in CS markedly increased NaCl, Mg, and Ca TAL. The transepithelial voltage must be oriented lumen
urinary excretion rates. In HHS patients, furosemide similarly positive, and the paracellular pathway must be able to
increased NaCl excretion, but failed to increase Mg and Ca conduct divalent cations. Regulatory events on divalent
excretion. Acute MgCl2 infusion in CS and ERH patient pro- cation reabsorption may be indirectly related to transepi-voked a dramatic increase in urinary calcium excretion without
thelial NaCl reabsorption via transepithelial voltage gen-change in NaCl excretion. When combined with MgCl2 infu-
sion, furosemide infusion remained able to induce normal natri- eration. However, growing experimental data suggest
uretic response, but was unable to increase urinary magnesium that peptide hormones and basolateral concentration of
and calcium excretion further. In HHS patients, calciuric re- divalent cation may regulate Mg and Ca transport insponse to MgCl2 infusion was blunted. cortical TAL without a change in transepithelial voltage,Conclusion. This study is the first to our knowledge to dem-
suggesting that a selective effect on paracellular perme-onstrate that homozygous mutations of PCLN-1 result in a
selective defect in paracellular Mg and Ca reabsorption in ability exists [1–4]. The paracellular pathway is also a
the TAL, with intact NaCl reabsorption ability at this site. In site for sodium transport, but transport of monovalent
and divalent cations may be dissociated [3, 4]. Whereas
the cellular mechanisms involved in transcellular active
Key words: nephrocalcinosis, hypomagnesemia-hypercalciuric syndrome,
NaCl reabsorption and transepithelial voltage genera-extrarenal hypomagnesemia, NaCl reabsorption, claudin 16, renal
transport. tion have been well described, until recently little was
known about the molecular nature of the TAL paracellu-Received for publication August 3, 2000
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to the claudin protein family [5]. This protein is expressed whose probands had typical HHS were investigated.
After informed consent was obtained from each partici-in human TAL tight junctions and might play a critical
role in the control of paracellular permeability for mag- pating subject (or the parents of the younger children),
a basal clinical and biological analysis was performed.nesium and calcium. Indeed, homozygous mutations in
the PCLN-1 gene are associated with a rare familial All subjects were analyzed in France for screening evalu-
ation in the Nephrology Units of Louise Michel (Evry)disease, the hypomagnesemia hypercalciuria syndrome
(HHS), which is secondary to marked renal magnesium and Laennec (Creil) General Hospitals or of Amiens
University Hospital. Appropriate venous blood andand calcium wasting [reviewed in 6]. Thus, it has been
proposed that PCLN-1 is a key in TAL divalent cation urine samples were drawn for evaluation of blood creati-
nine, Ca, Mg, phosphate, and urinary creatinine and Cahandling. However, to date there are no functional data
demonstrating that TAL magnesium and calcium reab- excretion.
More extensive baseline and dynamic studies weresorptions are actually impaired in patients presenting with
HHS and mutations in the PCLN-1 gene. The rationale performed in the two probands of each family in the
Departments of Physiology of Broussais and Neckerfor the present study was that if PCLN-1 is critical for
selective divalent cation paracellular permeability in the University Hospitals in Paris. Twenty-four–hour urines
were collected the day before the baseline studies andTAL, then a loss-of-function of PCLN-1 is expected,
first to induce a defect in renal magnesium and calcium were analyzed for Ca, Mg, Na, K, creatinine, and citrate.
Appropriate fasting urinary (120-minute collection pe-handling without affecting NaCl renal transport under
baseline conditions. Second, maneuvers that normally riod) and venous blood samples were analyzed for uri-
nary creatinine, Ca, Mg, phosphate and blood creatinine,inhibit divalent cation reabsorption in TAL, that is, furo-
semide and acute magnesium infusions, should be unable Na, Cl, K, total CO2, pH, total and ionized Ca, Mg,
phosphate, PTH 1-84, 25-hydroxy-vitamin D and 1,25-to decrease further divalent cation reabsorption at this
site in HHS patients. dihydroxy-vitamin D, active renin, and aldosterone.
Urinary concentration ability was assessed by 1-des-This study describes the clinical and biological charac-
teristics of two families bearing two new mutations (Gly- amino-[D-Arg8] (dDAVP) administration [7] and acidi-
fication ability by an acute oral load of either NH4Cl162Val, Ala139Val) in PCLN-1 as well as the results of
dynamic investigations conducted in the two unrelated or NaHCO3 [8]. The ability to reclaim filtered sodium
chloride renal handling was studied by either the abilityprobands, one hypomagnesemic patient with extrarenal
hypomagnesemia (ERH), and two control subjects (CSs). to lower sodium excretion under sodium diet deprivation
or assessment of fractional chloride reabsorption in theFirst, patients with genetically identified HHS have an
abnormally low renal magnesium and calcium reabsorp- diluting segment under conditions of maximal free water
clearance obtained by hypotonic saline infusion, as pre-tion without renal loss of NaCl. Second, the normal ef-
fects of acute furosemide infusion on calcium and magne- viously described [9, 10].
Genotyping. DNA was extracted from blood samplesium excretions were blunted in HHS patients, in spite
of normal natriuretic and chloruretic effects. In addition, according to the classic phenol extraction method. The
search for mutation was performed by amplification andacute magnesium infusion failed to increase calcium ex-
cretion in these patients, as it did in ERH patient and direct sequencing of each of the five exons of the PCLN-1
gene (Genbank accession NM-006580) using the primersCSs. To our knowledge, these data provide the first evi-
dence for functionality of the mutations described and described by Simon et al [5].
Double-strand sequencing was performed using thefor a major role of PCLN-1 in paracellular divalent cation
reabsorption in human TAL. In addition, in normal sub- dideoxy-termination method on an ABI 377 instrument
(Prism Big Dyee Terminators Cycle Sequencing kit; PEjects, acute MgCl2 infusion induced a calciuric response
without a change in NaCl excretion, and when combined Applied Biosystems, Foster City, CA, USA). Each indi-
vidual of the two kindred was genotyped by amplificationwith furosemide infusion, the calciuric response was
blunted but natriuretic response to furosemide was con- and specific allele detection test. The Ala139Val (GCG!
GTG) mutation located at exon 2 creates a BstXI siteserved. These data suggest a selective inhibitory effect
of hypermagnesemia on paracellular divalent cation per- with an amplicon size of 183 bp for wild-type individuals
and amplicons of 136 and 47 bp for homozygous-affectedmeability in human TAL, probably via a modification
of PCLN1 activity. subjects. Since the Gly162Val (GGAGTA) mutation lo-
cated at exon 3 does not modify any restriction enzyme
site, we used the mutagenically separated polymerase
METHODS
chain reaction (PCR) technique where both normal and
Patients mutant alleles are amplified in the same tube, using dif-
ferent length allele-specific primers [11]. The followingFamilies of HHS patients. Two unrelated consanguine-
ous kindreds (one from Portugal and one from Morocco) primers were designed with one forward primer and two
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reverse primers where additional deliberate differences measurement of urinary inulin, Ca and Mg, and serum
inulin, total and ultrafilterable (UF) Ca and Mg. For(underlined) were introduced to correspond to the mo-
chronic MgCl2 infusion, 40 mmol/day MgCl2 was infusedlecular variant and to reduce cross reactions between
after completion of the acute infusion over the 48 follow-the two alleles: Ex3F, 59-TGTCTGCCCATGTTGCC
ing hours.ATCCTG-39; Ex3RSGly, 59-GATATTCTAGCTGGG
Furosemide infusion. After two 30-minute control pe-TTTAG-39; and Ex3RLVal, 59-GCGTTGATGATTA
riods, a priming dose of furosemide (0.2 mg/kg bodyCTGCAAGTATTCTAGCTGGGTTCGT-39.
weight) was injected intravenously, and then followedPolymerase chain reactions were conducted in a 25 mL
by an infusion of 10 mg/hour in 0.9% saline solution atreaction volume containing 2.5 mL 10 3 PCR buffer
constant rate over two hours. After a single one-hour(500 mmol/L KCl, 100 mmol/L Tris-HCl, pH 8.3, 0.01%
equilibration period, two 30-minute urine collectionsgelatin), 2.0 mmol/L MgCl2, 10 mmol/L each of the four
were performed. In all periods, urinary inulin, Na, Cl,dNTPs, 5 pmol each of the three primers and 1 UAmpli-
Ca and Mg, and serum inulin, Na, Cl, total and UF CaTaq Gold DNA polymerase (Roche Molecular System,
and Mg were measured.USA). The first denaturation step (948C for 5 minutes)
was followed by 35 cycles: 948C for 45 seconds, 558C for Analytical methods
45 seconds, 728C for 45 seconds, and a final extension
Analytical methods used were described and refer-at 728C for 7 minutes. The amplification reaction yielded
enced in a previous article [12]. Plasma and urine concen-161 and 179 bp products for the Gly and Val alleles,
trations of inulin were measured according to the Schrein-respectively, which were resolved on a 2% agarose gel.
er’s method, pH and PCO2 using an automated pH andTwo groups of 96 normal volunteers and 96 subjects
gas analyzer (ABL 330, Radiometer, Copenhagen), cre-with idiopathic hypercalciuria were genotyped, using the
atinine by a colorimetric method (picric acid), Ca and MgPCR detection assays set up for both mutations, which
by atomic absorption spectrophotometry (Perkin Elmer,did not reveal any positive individual.
Model 3110), Na and K by specific electrodes (Beckman,Patient with extrarenal hypomagnesemia (ERH). A
model E2A), and phosphorus and urine citrate by color-40-year-old woman was referred to our laboratory for
imetry. Serum-ionized Ca was measured by an ion-selec-episodic tetany. Explorations revealed hypoparathyroid-
tive electrode (ICA 2, Radiometer, Copenhagen), theism caused by severe magnesium depletion of extrarenal
PTH concentration by a radio-immunometric methodorigin. Hypomagnesemia persisted despite a 3 g/day oral
(Allegro PTH; Nichols Institute, San Juan Capistrano,magnesium supplementation. Further investigations led
CA, USA), plasma 25-hydroxy-vitamin D by Preece’s
to conclude that she had a selective intestinal defect in method and 1,25-dihydroxy-vitamin D by radioreceptor
magnesium absorption. This patient was submitted to assay, plasma renin and aldosterone radioimmunoassay
acute and chronic magnesium infusion. kits (Pasteur Diagnostics, France, and Behring GmbH,
Control subjects. Two 30-year-old control women with- respectively). Serum UF Ca and UF Mg were obtained
out history of osteoporosis, lithiasis, and renal failure by a micropartition system (MPS 1; Amicon, Beverly,
were studied. MA, USA). Furosemide was obtained from Hoechst
(Paris, France), and inulin analog polyfructosan-S (Inu-Physiological studies: Protocol investigation
testt) from Laevozan GmbH (Linz, Austria).
During all of the tests, fasting patients and controls
were recumbent but were allowed to stand to void. All Calculations
maintained their usual diet with a normal NaCl intake Urinary Ca and Mg excretion variations could be due
the days before exploration. For these studies, urine was to GFR variations affecting the Ca and Mg filtered loads.
generally collected at 30-minute intervals, and venous Thus, we factored urinary Ca and Mg excretion values
blood was drawn through an indwelling catheter at the by GFR in order to assess the tubular Ca and Mg recla-
midpoint of each period. mations independently of GFR values. The fractional
Glomerular filtration rate (GFR) measurements. In all excretion of calcium and sodium (FECa/FENa) ratio was
studies, GFR was assessed through a continuous inulin used to discriminate between selective effects on tubular
analog infusion method. A priming dose of polyfructo- Ca reclamation that dissociate Ca and Na excretion and
san S (Inutestt), 30-mg/kg body weight, was injected intra- nonselective effects similarly affecting Ca and Na reab-
venously, followed by a constant Inutestt infusion (15 sorption [13].
mg/min/100 mL estimated GFR). Baseline urine collec-
tions were initiated after a one-hour equilibration period.
RESULTSAcute and chronic intravenous MgCl2 infusion. After
Basal genotype-phenotype relationshiptwo 30-minute control periods, four additional 30-minute
urine collections were obtained during continuous MgCl2 The two unrelated HHS consanguineous kindred (kin-
dred A from Portugal, kindred B from Morocco) wereinfusion (25 mmol in 5% dextrose over two hours) for
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Table 1. Basal biological characteristics of the two hypomagnesemia hypercalciuric syndrome (HHS) kindreds
Kindred A Kindred B
IA-1 IA-2 IIA-1 IIA-2 IIA-3 IB-1 IB-2 IIB-1 IIB-2 IIB-3 IIB-4
Age years 56 54 31 25 21 45 39 16 12 10 8
Sex male/female M F M F F M F F F F M
Nephrocalcinosis 2 2 2 1 2 2 2 2 1 2 2
Plasma
Calcium mmol/L 2.20 2.31 2.19 2.02 2.36 2.25 2.30 2.29 2.20 2.34 2.35
Magnesium mmol/L 0.69 0.79 0.71 0.39 0.67 0.76 0.68 0.83 0.61 0.85 0.81
Phosphate mmol/L 1.14 1.14 0.96 1.33 0.76 0.81 0.96 1.24 1.33 1.45 1.58
Creatinine lmol/L 137 74 78 112 84 76 48 49 62 41 70
Urine
Calcium excretion
mmol/mmol creatinine 0.54 0.55 0.17 0.67 0.45 0.30 0.60 0.07 1.39 0.18 0.15
Status 1/2 1/2 1/2 1/1 1/2 1/2 1/2 2/2 1/1 2/2 1/2
Nephrocalcinosis scores are: 1 presence, 2 absence. Status scores are: 1/1 affected, 1/2 carrier, 2/2 normal.
Fig. 1. The G162V and A139V mutations of
the paracellin-1 gene and their segregation in
two hypomagnesemia hypercalciuric syndrome
(HHS) families. (A) HHS families. Symbols
refer to affected individuals (d), carriers (ver-
tically striped circles and squares), and healthy
individuals (s, h). The segregation of each
mutation is shown by an allele-specific PCR
assay (Methods section). (B) Electrophero-
grams documenting each type of mutation are
shown in a trio composed (from left to right)
of a control, an affected subject, and a hetero-
zygous carrier. All sequences shown are in the
forward direction with respect to paracellin-1
mRNA.
investigated through two probands who had typical fea- both mutations did not reveal any positive individual out
of 96 normal volunteers.tures of HHS. The proband of kindred A (subject IIA-2)
was a 25-year-old woman with hypercalciuria, bilateral Urinary calcium excretions and serum calcium concen-
nephrocalcinosis, and hypomagnesemia (Table 1). The trations in the relatives were within the normal ranges.
proband of kindred B (subject IIB-2) was a 12-year-old However, heterozygous first relatives had a tendency to-
girl with similar features. Both had a medical history of ward hypercalciuria or mild hypomagnesemia (Table 1).
constant growth retardation (22 SD). The first-degree
Biological characteristics of the probands andrelatives of both patients were asymptomatic.
ERH patientsDirect sequencing of the PCLN1 gene revealed that
the proband of kindred A was homozygous for a mis- HHS patients had a defect in renal magnesium and cal-
cium reabsorption, but no renal loss of sodium. To demon-sense mutation Gly162Val (GGA!GTA) located at
exon 3 and that the proband of kindred B was homozy- strate the defect in renal magnesium and calcium reab-
sorption, baseline data in HHS patients were comparedgous for another new missense mutation Ala139Val
(GCG!GTG) located at exon 2 (Fig. 1). These muta- with those obtained in one patient with extrarenal hypo-
magnesemia (Table 2).tions were analyzed through PCR amplification followed
by a BstXI enzymatic digestion for the A139V mutation In HHS patient 1 (subject IIA-2 with HHS), the severe
reduction in serum Mg concentration was associated withor by specific MS-PCR for the G162V mutation. Geno-
types confirmed the heterozygosity of each parent. Sib- a moderate reduction in serum total and ionized Ca
concentrations (Table 2). Patient 2 (subject IIB-2 withlings of each affected proband were either heterozygous
carrier or unaffected. PCR detection assays set up for HHS) had moderate hypomagnesemia and a normal cal-
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Table 2. Phenotypical evaluation of the patients with hypomagnesemia hypercalciuria syndromes (HHS 1 and 2) and one patient
with extrarenal hypomagnesemia (ERH)
HHS 1 HHS 2 ERH Normal valuesa
Age 25 12 40
Body weight kg 102 45 61
Height m 1.51 1.43 1.60
GFR mL·min21 50 60 113
(normal values) (81–132) (89–165) (70–118)
Blood
Creatinine lmol/L 112 71 54 60–105
Calcium mmol/L 2.02 2.24 1.84 2.17–2.57
Ultrafiltrable calcium mmol/L 1.22 1.53 1.17 1.34–1.62
Ionized Ca21 mmol/L 1.05 1.22 0.97 1.14–1.35
Magnesium mmol/L 0.39 0.58 0.37 0.71–1.04
Phosphate mmol/L 1.22 1.39 1.10 0.80–1.40
TmPi mmol/L 1.14 1.64 1.08 adult: 0.75–1.37
child: 1.47–2.07
Sodium mmol/L 139 137 140 135–145
Potassium mmol/L 4.3 3.8 4.1 3.5–4.5
Chloride mmol/L 98 104 100 95–105
Blood pH 7.38 7.37 7.35 7.37–7.42
Total CO2 mmol/L 29 29 27.4 24–30
Plasma
Renin pg/mL 21 22 NA 15–50
Aldosterone pg/mL 239 251 NA 30–360
24-hour urine mmol/24 h
Calcium 8.0 8.9 0.2
Magnesium 3.0 3.9 0.2
Sodium 155 62 134
Potassium 72 31 35
Citrate 0.30 0.98 NA .1.67
Maximum UOsm after dDAVP mOsm/kg H2O 360 510 NA .850
Urinary acidification defect distal distal NA
Distal fractional chloride reabsorption 84–88% NA NA .75%
Adaptation to low NaCl diet NA conserved NA
Abbreviations are: UF, ultrafilterable; TmPi, renal tubular maximum phosphate; dDAVP, 1-desamino-[D-Arg8]; NA, not available; GFR, glomerular filtration
rate.
a Normal values from our laboratory
cium concentration. The patient with ERH presented as whatever the index considered, the distal fractional chlo-
ride reabsorption was normal: CH2O/(CH2O 1 CCl) valuesthe HHS1 patient with a severe Mg depletion and low
Ca concentration. ranged between 84% and 88%, which stand within the
normal range (.75%) in our laboratory and others [9].In the ERH patient, urinary magnesium and calcium
excretion were very low and appropriate to the low se- In addition, CH2O/GFR values were normal with regard
to the distal delivery (CH2O 1 CCl)/GFR, according to therum magnesium and calcium concentrations. These data
in ERH patient are in agreement with data observed reference frame previously established in normal sub-
jects receiving various NaCl intakes [10]. These datain experimental human magnesium depletion [14]. In
contrast, in the HHS1 patient with similar severe Mg suggest that PCLN-1 mutations did not alter tubular
NaCl reabsorption.depletion, despite the similarly low serum Ca value, uri-
nary magnesium and calcium excretion was much higher In addition, inulin clearance (GFR) was abnormally
low in both patients with HHS. This moderate renaland thus inappropriate. In the HHS patient 2 with mod-
erate Mg depletion, the serum Ca concentration was failure was associated with mild proteinuria (,1 g/24 h)
without glycosuria or abnormal aminoaciduria. In bothnormal, but urinary Ca and Mg excretions were also
inappropriately high. Thus, renal tubular Mg and Ca patients, maximal urinary osmolality values reached
after dDAVP administration were abnormally low.reabsorption was markedly decreased in HHS patients.
In patients with HHS, levels of circulating renin and Plasma acid-base values, estimated from plasma pH and
total CO2 values, were normal. However, in patient 1,aldosterone were normal, suggesting normal blood and
extracellular volume. In addition, HHS patient 2 was urinary PCO2 remained close to venous PCO2 after acute
oral NaHCO3 load, whereas renal tubular maximumnormally able to lower her sodium excretion below 10
mmol/day during sodium deprivation, and in HHS pa- (Tm) for bicarbonate was normal (30 mmol/L GFR; nor-
mal value range is 23 to 30). Patient 2 failed to have atient 1, sodium reabsorption in the diluting segment was
normal as assessed by hypotonic saline infusion. Indeed, decrease in urinary pH and increase in net proton excre-
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Table 3. Effects of furosemide infusion in patients with hypomagnesemia hypercalciuria syndrome (HHS 1 and 2)
and control subjects (CS 1 and 2)
Furosemide HHS 1 HHS 2 CS 1 CS 2
GFR mL/min 2 53 58 80 79
1 51 56 84 66
Serum UF Mg mmol/L 2 0.69 0.50 0.59 0.58
1 0.67 0.44 0.54 0.56
Serum UF Ca mmol/L 2 1.39 1.44 1.31 1.38
1 1.41 1.48 1.32 1.34
Urinary Mg mmol/L GF 2 0.51 0.07 0.05 0.04
1 0.51 0.09 0.10 0.15
Urinary Ca mmol/L GF 2 0.16 0.15 0.02 0.04
1 0.20 0.16 0.18 0.24
Urinary Na mmol/L GF 2 2.71 2.23 2.69 3.80
1 22.41 18.87 13.66 20.74
Urinary Cl mmol/L GF 2 3.84 3.30 2.82 3.93
1 24.67 21.16 15.87 23.33
Results are the means of two 30-minute baseline collection periods (2) or of the two final 30-minute collection periods (1) during furosemide infusion. Abbreviations
are UF, ultrafilterable; GFR, glomerular filtrate rate.
tion after oral NH4Cl load: Minimal urinary pH was 5.8 approximately two- to ninefold, respectively, in CSs,
whereas in HHS patients, the drug had almost no effect(normal value ,5.4), and maximal net acid excretion
reached only 24 mmol/min (normal value .80). Both on Mg and Ca excretion. Finally, all subjects showed
identical Na and Cl excretion under baseline conditions,subjects had hypocitraturia. The latter data suggested in
the two probands distal defect of urinary acidification, and they were markedly and similarly increased approxi-
mately sixfold by furosemide.probably related to nephrocalcinosis.
These data obtained with furosemide in HHS patients
Magnesuric and calciuric, but not natriuretic, indicate the presence of a defect in paracellular reabsorp-
responses to furosemide were blunted in patients tion of divalent cation in TAL (paracellular Na reabsorp-
with homozygous mutations of the PCLN-1 gene tion remaining normal at this site), which is due to loss
of function mutations in PCLN-1.Furosemide is well known to inhibit transcellular NaCl
reabsorption in TAL, which in turn suppresses the trans-
Acute MgCl2 infusion elicited a calciuric, but notepithelial potential difference and thus inhibits Ca, Mg,
natriuretic, response in the normal subject andand Na reabsorption through the paracellular pathway.
ERH patientIf PCLN-1 is critical for paracellular magnesium and
calcium reabsorption in TAL but not for paracellular Experimental studies in rat, using in vivo microper-
fused Henle’s loop, have shown that an acute increaseNa reabsorption at this site, and if PCLN-1 mutations
are responsible for loss of function of the protein, then in plasma magnesium concentration depressed absolute
magnesium and calcium, but not sodium, absorption [15].furosemide can be expected in HHS patients, first, to
normally inhibit NaCl reabsorption and increase NaCl Because the filtered load of calcium but not the filtered
load of magnesium remains unchanged during acuteexcretion. Second, it would be unable to increase further
calcium and magnesium excretion (because calcium and magnesium infusion in humans, the increase in calcium
excretion is a better index of the inhibitory effect ofmagnesium reabsorption is already suppressed). Furose-
mide infusions were performed in two CSs and in the peritubular magnesium on renal tubular divalent cation
transport.two patients with HHS (Table 3). Patient 1 was studied
after a 48-hour MgCl2 infusion in order to normalize her As shown in Table 4, acute MgCl2 infusion in the CS
and the patient with ERH induced a tenfold increase infiltered load of calcium and magnesium.
Before the furosemide infusion, serum ultrafilterable urinary calcium excretion. As discussed previously in
this article, these changes in calcium excretion occurred(UF) Ca concentrations were similar in patients with
HHS and the controls. However, Ca excretion markedly despite almost no change in serum UF Ca concentration
and therefore reflected a decrease in renal calcium reab-differed and was approximately five times higher in HHS
patients than in controls. MgCl2-infused HHS patient 1 sorption. Urinary sodium excretion remained almost
constant in both subjects during MgCl2 infusion (data nothad a normalized serum UF magnesium concentration
and a marked increase in magnesium excretion, while shown). Accordingly, the FECa/FENa ratio, which should
remain constant if sodium reabsorption was primarilyHHS patient 2 had a spontaneous low serum UF Mg
concentration and conserved magnesium excretion. Dur- affected [13, 16], increased in the CS and ERH patient
in proportion to urinary calcium excretion. These dataing furosemide infusion, Mg and Ca excretions increased
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Table 4. Effects of MgCl2 infusion on renal calcium handling in
patients with hypomagnesemia hypercalciuria syndrome (HHS),
one patient with extrarenal hypomagnesemia (ERH),
and one control subject (CS)
Baseline 1 hour 2 hours 48 hours
Serum UF Mg mmol/L
HHS 1 0.24 0.65 1.07 0.69
HHS 2 0.49 0.70 1.31
ERH 0.22 0.71 1.08 0.77
CS 0.61 1.02 1.36
Serum, UF Ca mmol/L
HHS 1 1.22 1.16 1.17 1.39
HHS 2 1.53 1.53 1.53
ERH 1.21 1.17 1.16 1.36
CS 1.49 1.57 1.54
Urinary Ca mmol/L GF
HHS 1 0.12 0.17 0.18 0.16
HHS 2 0.12 0.23 0.23
ERH 0.001 0.003 0.016 0.009
CS 0.02 0.12 0.20
FECa/FENa
HHS 1 10.0 13.6 10.6 5.9
HHS 2 8.7 7.3 5.0
ERH 0.1 0.2 1.2 0.3
CS 1.7 11.5 13.4
Chronic MgCl2 infusion was performed in HHS 1 patient and ERH patient. Fig. 2. Relationships between urinary magnesium excretion rate (fac-
Abbreviations are: UF, ultrafilterable; FE, fractional excretion. tored by GFR) and ultrafilterable (UF) Mg serum concentration before
and during acute infusion of MgCl2 in the patients with hypomagnese-
mia-hypercalciuric syndrome (HHS; s, n, dotted line), one patient with
extrarenal hypomagnesemia (ERH; d), and one control subject (CS;
Table 5. Effects of furosemide infusion in one control subject first m, dashed line). The bisector on this figure (solid line) corresponds
when normomagnesemic, and second when hypermagnesemic to the theoretical value of magnesium excretion if no magnesium is
(after MgCl2 infusion) reabsorbed.
Serum UF Urinary excretions
mmol/L mmol/L GF
GFR
mL/min Ca Mg Ca Mg Na Cl
in agreement with previous data in animals. In addition,
Baseline 80 1.31 0.59 0.02 0.05 2.69 2.82 these results indicate that acute hypermagnesemia inhib-Furosemide 84 1.32 0.55 0.18 0.10 13.66 15.87
its divalent cation reabsorption independently of Na re-MgCl2 82 1.38 1.09 0.11 0.45 3.06 4.04
MgCl2 1 furosemide 77 1.38 0.93 0.19 0.49 14.58 17.00 absorption, suggesting a selective effect on paracellular
Abbreviations are: GFR, glomerular filtration rate; MgCl2, MgCl2 infusion; pathway permeability.
Furosemide, furosemide infusion; GF, glomerular filtrate. The inhibitory effect of hypermagnesemia on TAL
magnesium reabsorption in CSs contributes to the appar-
ent saturation in renal magnesium reabsorption that is
observed during acute magnesium infusion [17]. It hasindicate that an increase in plasma magnesium concentra-
been shown in dogs and rats [15, 18] that the apparenttion also inhibits renal calcium reabsorption in humans
saturation (or Tm) in renal magnesium reabsorption isvia a mechanism independent of sodium reabsorption.
not accounted for by a genuine saturable process butTo localize the inhibitory effect of acute magnesium
results from two components: proximal tubule Mg reab-infusion on calcium reabsorption in renal tubules, furose-
sorption, which increases with increasing luminal Mgmide infusion was repeated in one CS in whom hyper-
concentration, and TAL Mg reabsorption, which is firstmagnesemia was induced by MgCl2 infusion (Table 5).
enhanced due to increasing TAL Mg delivery and thenMgCl2 infusion induced a six- and tenfold increase in
declines because of the inhibitory effect of hypermagnes-urinary Ca and Mg excretion, respectively, without any
emia on the basolataral side of the epithelium. As shownchange in urinary NaCl excretion. During the subsequent
in Figure 2, in acutely MgCl2-infused CS, the relationshipfurosemide infusion, urinary Ca excretion rose less than
between urinary Mg excretion (factored by GFR) andtwofold (vs. 9-fold when normomagnesemic), and the
serum UF Mg allowed calculation of an apparent Tmmagnesuric response was completely blunted, whereas
for renal Mg reabsorption of 0.56 mmol/L glomerularthe natriuretic response remained intact (Table 5). The
filtrate (GF) [17]. In the patient with ERH in whomlack of additive effects of MgCl2 and furosemide infu-
serum UF Mg rose progressively, urinary Mg, initiallysions on divalent cation urinary excretion supports the
close to zero, slowly rose until the normal serum UF Mgconcept in humans that the calciuric and magnesuric
effects of MgCl2 infusion are located in the TAL, which is concentration was reached. Then it followed the same
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relationship as the normal subject, indicating a normal recent follow-up study [6]. About nothing was known
about the site and mechanism(s) of the renal defect(s)apparent renal Tm for Mg.
in HHS until Simon et al demonstrated homozygous
Calciuric response to acute MgCl2 infusion was mutations in the paracellin-1 gene, a newly described
blunted in patients with homozygous mutations paracellular protein that is selectively expressed in hu-
of the PCLN-1 gene man TAL [5].
We report the cases of two patients from two unrelatedWe have shown that acute MgCl2 infusion inhibits Ca
and Mg reabsorption in TAL without altering urinary families; both issued from two full-cousin parents and
presented with typical features corresponding to theNaCl excretion, suggesting that a selective inhibition of
divalent cation paracellular pathway permeability exists. HHS phenotype [6]. Genetic analysis was performed in
the two families and two as yet undescribed homozygousIf PCLN-1 is critical for paracellular divalent cation reab-
sorption in TAL and if PCLN-1 mutations are responsi- mutations (Gly162Val, Ala139Val) of the paracellin-1
were found in the probands of each family. Heterozygousble for loss of function of the protein, then in HHS
patients MgCl2 infusion should not be able to increase first relatives had a tendency to hypercalciuria or mild
hypomagnesemia.urinary Ca excretion further. Indeed, in HHS patients,
the UF Ca concentration remained unchanged during In the two patients with homozygous mutations in the
PCLN-1 gene, an impairment in renal tubular magne-acute MgCl2 infusion, and urinary calcium excretion rates
increased only slightly (less than 2-fold), while the FECa/ sium and calcium reabsorption with normal NaCl recla-
mation was demonstrated. Accordingly, comparativeFENa ratio remained unchanged (Table 4). Thus, in HHS
patients, TAL calcium reabsorption was poorly influ- studies performed under baseline condition in one pa-
tient with ERH and in HHS patients demonstrated thatenced by the MgCl2 infusion. The blunted calciuric re-
sponse to magnesium infusion was associated with a the magnesium and calcium excretion in HHS patients
were inappropriately high when compared with serummarked impairment in renal Mg handling. As shown in
magnesium and calcium concentrations. However, renalFigure 2, the relationship between urinary Mg excretion
NaCl reabsorption in HHS patients was intact. There(factored by GFR) and serum UF Mg measured during
was no clinical evidence of extracellular fluid volumeMgCl2 infusion allowed calculation of apparent Tm val-
contraction. Furthermore, basal circulating renin and al-ues for renal Mg reabsorption, which were abnormally
dosterone concentrations were normal and adapted tolow, approximately 0.30 mmol/L GF for both patients.
the normal Na intake. Finally, abnormal NaCl reclama-Taken together, the data obtained with MgCl2 infusion
tion in the diluting segment of the nephron was excludedin HHS patients confirm the presence of a selective de-
in one patient, while the other was able to adapt normallyfect in the paracellular pathway permeability to divalent
to a sodium deprived diet.cation in TAL, due to loss of function mutations in
Two maneuvers were used to localize the defect inPCLN-1.
divalent cation reabsorption in the renal tubule in HHS
patients: furosemide and MgCl2 infusion.DISCUSSION The furosemide infusion was performed first. Assum-
Renal magnesium wasting is usually defined as a uri- ing that HHS is due to an abnormally low paracellular
nary excretion greater than 1 mmol/day in the presence pathway permeability for Mg and Ca in the TAL, NaCl
of hypomagnesemia (serum Mg ,0.70 mmol/L). It may being normally reabsorbed at this site, furosemide infu-
be related to drugs, to some endocrine disorders, and to sion is expected to induce a normal increase in NaCl
relatively uncommon familial renal tubular defects [19]. excretion but to be unable to inhibit further the paracellu-
In Bartter’s and Gitelman’s syndromes inherited as au- lar Mg and Ca reabsorption in TAL (which are already
tosomal recessive traits, a renal Mg loss is associated abolished). Therefore, any increase in Mg and Ca excre-
with hypokalemia, metabolic alkalosis, and secondary tion observed in CSs after the furosemide infusion should
hyperaldosteronism [reviewed in 20, 21]. In the HHS be blunted in patients with HHS. Because Ca and Mg
(classified MIM 248,250), the plasma potassium level is reabsorption in the TAL is directly related to Ca and
normal and metabolic alkalosis is absent. The cardinal Mg delivery, in order to obtain similar serum values to
clinical feature in HHS is the development of nephrocal- those of controls, extracellular Mg and Ca concentrations
cinosis, which is consistently associated with polyuria were normalized by chronic magnesium infusion in pa-
and occasionally with nephrolithiasis. Growth retarda- tient 1 with HHS. As expected, despite natriuretic and
tion may be observed, probably dependent on the chloruretic responses to furosemide of similar magnitude
nephrocalcinosis-related renal insufficiency. HHS gener- in the patients with HHS and controls, the magnesuric
ally progresses toward end-stage renal failure, and the and calciuric responses were blunted in the patients.
presence of severe nephrocalcinosis is associated with a Data obtained in the non-MgCl2–infused patient (HHS
patient 2) provide direct evidence that the abnormalrapid alteration of renal function, as established in a
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response to furosemide in patient 1 is not due to MgCl2 and PDte. Quamme and Dirks, in experiments using in
vivo microperfusion of Henle’s loop, showed that acuteinfusion per se. This blunted response is likely due to
and selective increase in plasma Mg concentration inan absence of Mg and Ca paracellular reabsorption in
TPTX rats inhibits divalent cation, but not NaCl absorp-the TAL of patients with HHS. In addition, the normal
tion [15]. Additionally, in rat and mouse TAL isolatednatriuretic response to furosemide further supports a
in vitro it has been shown that a selective increase innormal reabsorption of NaCl in the TAL of HHS pa-
bath calcium concentration impairs Ca and Mg reabsorp-tients.
tion, but has no effect on PDte, with either no changeSecond, we used acute MgCl2 infusion. Experimental
(in mouse) [4] or a borderline reduction (in rat) in NaCldata in rats have shown that an acute increase in plasma
transport [24]. These data clearly suggest that increasingmagnesium concentration selectively inhibits divalent
extracellular calcium or magnesium concentration inhib-cation reabsorption in the TAL [15]. The present study
its their own reabsorption by a selective effect on theconfirms that an acute MgCl2 infusion also selectively
paracellular pathway. Our present study supports suchinhibits divalent cation reabsorption in human TAL, as
a similar selective effect in humans. Indeed, in CS, assuggested by the absence of a natriuretic response, and
well as in ERH patient, acute magnesium infusion aloneconfirmed by the absence of additive calciuric and mag-
does not exert any natriuretic effect. In addition, acutenesuric effects of acute MgCl2 and furosemide infusion
hypermagnesemia in CS greatly reduces the calciuric andin one CS whereas the natriuretic effect of furosemide
magnesuric effects of furosemide infusion but does notwas conserved. In HHS patients, urinary calcium excre-
alter the natriuretic response to furosemide. Altogether,tion was poorly influenced by MgCl2 infusion, which fur-
these data suggest that in humans, there is a selectivether confirms that divalent cation paracellular reabsorp-
inhibitory effect of high basolateral Mg21/Ca21 concen-tion in the TAL is inhibited in these patients.
tration on TAL paracellular divalent cation reabsorp-Our results showing a blunted divalent cation urinary
tion, as previously shown in animal models [4].response to two different maneuvers (furosemide and
In conclusion, our study shows that the loss of functionMgCl2 infusion), which both inhibit divalent cation reab- mutations in paracellin-1 results in a selective alterationsorption in TAL of normal subjects, strongly support the
in TAL paracellular Mg and Ca permeability, which ispresence of a primary defect in magnesium and calcium
responsible for the selective defect in Mg and Ca renalreabsorption at this site in HHS patients. In addition,
reabsorption present in patients with HHS. In addition,NaCl reclamation in the diluting segment remains nor-
these data support the theory of a selective regulatorymal in these patients. Altogether, the results suggest that
effect of basolateral Ca21 and Mg21 concentrations on
PCLN1 is essential for divalent cation but not for sodium their own paracellular permeability in TAL. Because
paracellular permeability in the TAL. PCLN-1 bridges the paracellular junctions, it is in contact
A primary defect located in the distal convoluted tu- with both the intracellular and extracellular fluid. Thus,
bule (DCT) was unlikely in HHS for at least two reasons. the intracellular domain possibly regulates the divalent
First, calcium and magnesium reabsorption in the DCT cation paracellular pathway through the basolateral Ca/
are active and mediated by distinct transcellular trans- Mg-sensing receptor via intracellular messengers [4]. In
port [22], rendering unlikely that a mutation of the addition, the high density of negative charges of the first
PCLN-1 gene results in a primary defect in tubular reab- extracellular domain of PCLN-1, which likely contrib-
sorption of both divalent cations at this site. Second, utes to the cationic selectivity of the paracellular path-
Simon et al did not find PCLN-1 protein expression in way, could be a divalent cation sensor [5]. Further studies
human DCT [5]. are required to determine the precise cellular and molec-
Moreover, the present study provides additional infor- ular mechanisms of extracellular divalent cation concen-
mation on the mechanism of the regulatory effect of tration on paracellular PCLN-1 activity in the TAL.
basolateral calcium and magnesium concentration on
their own reabsorption in the TAL, which is still debated. ACKNOWLEDGMENTS
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